ACTL10 and acute myeloid leukemia: Similarly, lower levels of ACTL10 DNA methylation were associated with a longer EFS (P<0.0001; log-rank test; Fig. 2B and C) and OS (P<0.0001; log-rank test; Fig. 2B and C) in patients with AML who had received different treatment regimens.